HMEC Transfection Reagent (Mammary Epithelial, Breast Cancer Cells)

Altogen Biosystems is a recognized manufacturer and research corporation for genetic research. Custom research opportunities and supplementary experiments include xenografts, drug testing, quick cell line generation, RNAi testing and more. Dedicated to assisting laboratories with useful and specialized services, Altogen Biosystems endeavors to improve modern pharmaceutical discoveries. Visit the official website and catalog for breast cancer xenograft models and assorted tools for custom research.

HMEC cells were derived from the glandular tissue of a human patient, and are one of the primary breast cancer in vitro  models available to researchers. The HMEC cell line is capable of acetylated LDL uptake, and expresses several factors such as von Willebrand's factor. The cells are important for biomedical research into the morphological and physiological evolution of breast cancer. Growing in cuboidal colonies with characteristic swirls, HMEC cells can be efficiently transfected with liposomic reagents , giving information as to how breast cancer tissue is affected by foreign substances and internal mutations in cellular genomes.

The human mammary epithelial cancer (HMEC) cell line was derived from the glandular tissue of a patient suffering from breast cancer. Research studies on the HMEC cell line have shown the cells exhibiting a cuboidal morphology with a series of patterned swirls.  The HMEC cell line is very useful in pre-clinical biomedical research done at Altogen Biosystems involving breast cancer treatments.   Transfection Reagent for HMEC Cells (Mammary Epithelial, Breast Cancer Cells)